BWAY Brainsway

BrainsWay’s Deep TMS Takes Center Stage at Clinical TMS Society Annual Poster Session

BrainsWay’s Deep TMS Takes Center Stage at Clinical TMS Society Annual Poster Session
EN
06/10/2020

Underlying

BWAYBrainsway

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Brainsway

 PRESS RELEASE
Free
BWAY BRAINSWAY

BrainsWay Reports Third Quarter 2025 Financial Results and Operational...

BrainsWay Reports Third Quarter 2025 Financial Results and Operational Highlights Revenue increased 29% to $13.5 million in Q3 2025 as compared with Q3 2024 Operating income totaled $1.3 million and Adjusted EBITDA rose approximately 80% to $2.0 million in Q3 2025, as compared with Q3 2024 Remaining performance obligations increased to $65 million FDA cleared an accelerated protocol for Deep TMS treatment of patients with major depressive disorder (MDD) Raised midpoint of full-year 2025 Revenue and EBITDA guidance Conference call to be held today at 8:30 AM ET BURLINGTON, Mass. and JE...

November 11, 2025 1 EN
 PRESS RELEASE
Free
BWAY BRAINSWAY

BrainsWay Reports National Institutes of Health Grant to Leading U.S. ...

BrainsWay Reports National Institutes of Health Grant to Leading U.S. Research Team Investigating Accelerated Deep TMS for Treatment of Alcohol Use Disorder New NIH grant awards $2.5 million over 5 years for mechanistic study BURLINGTON, Mass. and JERUSALEM, Nov. 04, 2025 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that the U.S. National Institutes of Health (NIH) has awarded a new grant – totaling approximately $2.5 million over f...

November 4, 2025 1 EN
 PRESS RELEASE
Free
BWAY BRAINSWAY

BrainsWay to Report Third Quarter 2025 Financial Results on November 1...

BrainsWay to Report Third Quarter 2025 Financial Results on November 11, 2025 BURLINGTON, Mass. and JERUSALEM, Oct. 28, 2025 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that it will report its third quarter 2025 financial results, as well as operational highlights, before the open of the U.S. financial markets on Tuesday, November 11, 2025. The Company will host a conference call and webcast at 8:30 AM Eastern Time to discuss the fin...

October 28, 2025 1 EN
 PRESS RELEASE
Free
BWAY BRAINSWAY

BrainsWay Announces Additional Minority-Stake Investments in Leading U...

BrainsWay Announces Additional Minority-Stake Investments in Leading U.S. Mental Health Providers Recent agreements with two additional U.S. mental health providers bring total to four in 2025 Strategy seeks to drive long-term shareholder value BURLINGTON, Mass. and JERUSALEM, Oct. 27, 2025 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced it has entered into two additional minority stake strategic investments, including an equity financ...

October 27, 2025 1 EN
 PRESS RELEASE
Free
BWAY BRAINSWAY

BrainsWay Receives FDA Clearance for Accelerated Deep TMS Protocol for...

BrainsWay Receives FDA Clearance for Accelerated Deep TMS Protocol for Non-Invasive Treatment of Major Depressive Disorder (MDD) Clinical data shows that BrainsWay’s new accelerated stimulation protocol is comparable to standard Deep TMS in depression score improvement, response and remission The accelerated protocol is now commercially available in the United States, expanding patient and provider access BURLINGTON, Mass. and JERUSALEM, Sept. 16, 2025 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neuros...

September 16, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch